Recently, two papers from the Karin laboratory showed that p62-dependent Nrf2 activation is essential for the development of hepatocellular carcinoma (HCC) and malignant progression of pancreatic ductal adenocarcinoma [30,31], suggesting a pro-tumoral activity of p62. The gene discussed is SQSTM1; the disease is pancreatic ductal adenocarcinoma.